Long-Term Outcome and Toxicities of Intraoperative Radiotherapy for High-Risk Neuroblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 3, 2007, Pages 858-864

  Gillis, Amy M ^a   Sutton, Elizabeth ^a   DeWitt, Kelly D ^a   Matthay, Katherine K ^a   Weinberg, Vivian ^a   Fisch, Benjamin M ^a   Chan, Albert ^a   Gooding, Charles ^a   Daldrup Link, Heike ^a   Wara, William M ^a   Farmer, Diana L ^a   Harrison, Michael R ^a   Haas Kogan, Daphne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

High risk; Intraoperative radiotherapy; IORT; Local control; Neuroblastoma; Pediatric

Indexed keywords

DISEASES; HEALTH RISKS; ONCOLOGY; PROBABILITY; TOXICITY;

INTRAOPERATIVE RADIOTHERAPY; LYMPH NODES; NEUROBLASTOMA; THERAPEUTIC EFFECTS;

RADIOTHERAPY;

ADOLESCENT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INFANT; INTRAOPERATIVE RADIOTHERAPY; KAPLAN MEIER METHOD; LONG TERM CARE; LYMPH NODE; MALE; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; STENOSIS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; INFANT; INTRAOPERATIVE PERIOD; NEOPLASM RECURRENCE, LOCAL; NEUROBLASTOMA; PROGNOSIS; TREATMENT OUTCOME;

EID: 34548679364     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.006     Document Type: Article

References (36)

1. Matthay K.K., and Yamashiro D. Neuroblastoma. In: Bast R.C., Kufe D.W., Pollock R.E., et al. (Eds). Cancer medicine (2000), BC Decker, London, England 2185-2197
2. Goldsby R.E., and Matthay K.K. Neuroblastoma: Evolving therapies for a disease with many faces. Paediatr Drugs 6 (2004) 107-122
3. Cheung N.V., and Heller G. Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 9 (1991) 1050-1058
4. Haas-Kogan D.A., Fisch B.M., Wara W.M., et al. Intraoperative radiation therapy for high-risk pediatric neuroblastoma. Int J Radiat Oncol Biol Phys 47 (2000) 985-992
5. Kiely E.M. The surgical challenge of neuroblastoma. J Pediatr Surg 29 (1994) 128-133
6. Kushner B.H., O'Reilly R.J., Mandell L.R., et al. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma. J Clin Oncol 9 (1991) 274-279
7. Ladenstein R., Lasset C., Hartmann O., et al. Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: A report from the European Group for Bone Marrow Transplantation. J Clin Oncol 11 (1993) 2330-2341
8. Matthay K.K., Atkinson J.B., Stram D.O., et al. Patterns of relapse after autologous purged bone marrow transplantations for neuroblastoma: A Children's Cancer Group pilot study. J Clin Oncol 11 (1993) 2226-2233
9. Matthay K.K., Seeger R.C., Reynolds C.P., et al. Allogenic versus autologous purged bone marrow transplantation for neuroblastoma: A report from the Children's Cancer Group. J Clin Oncol 12 (1994) 2382-2389
10. Matthay K.K., O'Leary M.C., Ramsay N.K., et al. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: Review of recent Children's Cancer Group results. Eur J Cancer 31A (1995) 572-575
11. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 341 (1999) 1165-1173
12. Ohnuma N., Takahashi H., Kaneko M., et al. Treatment combined with bone marrow transplantation for advanced neuroblastoma: An analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan. Med Pediatr Oncol 24 (1995) 181-187
13. Philip T., Zucker J.M., Bernard J.L., et al. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup?. J Clin Oncol 9 (1991) 1037-1044
14. Pole J.G., Casper J., Elfenbein G., et al. High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9 (1991) 152-158
15. Wolden S.L., Gollamudi S.V., Kushner B.H., et al. Local control with multimodality therapy for stage 4 neuroblastoma. Int J Radiat Oncol Biol Phys 46 (2000) 969-974
16. Matthay K.K. Neuroblastoma: Biology and therapy. Oncology 11 (1997) 1857-1866
17. Garaventa A., Boni L., Lo Piccolo M.S., et al. Localized unresectable neuroblastoma: Results of treatment based on clinical prognostic factors. Ann Oncol 13 (2002) 956-964
18. Marcus K.C., and Tarbell N.J. The changing role of radiotherapy in the treatment of neuroblastoma. Semin Radiat Oncol 7 (1997) 195-203
19. Brodeur G.M., Seeger R.C., Barrett A., et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. Prog Clin Biol Res 271 (1988) 509-524
20. Brodeur G., Pritchard J., Berthold F., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11 (1993) 1466-1477
21. Leavey P.J., Odom L.F., Poole M., et al. Intra-operative radiation therapy in pediatric neuroblastoma. Med Pediatr Oncol 28 (1997) 424-428
22. Aitken D.R., Hopkins G.A., Archambeau J.O., et al. Intraoperative radiotherapy in the treatment of neuroblastoma: Report of a pilot study. Ann Surg Oncol 2 (1995) 343-350
23. Meurk M.L., Goer D.A., Spalek G., et al. The Mobetron: A new concept for IORT. Front Radiat Ther Oncol 31 (1997) 65-70
24. Matthay K.K., Perez C., Seeger R.C., et al. Successful treatment of stage III neuroblastoma based on prospective biologic staging: A Children's Cancer Group study. J Clin Oncol 16 (1998) 1256-1264
25. Powis M.R., Imeson J.D., and Holmes S.J. The effect of complete excision on stage III neuroblastoma: A report of the European Neuroblastoma Study Group. J Pediatr Surg 31 (1996) 516-519
26. Bowman L.C., Castleberry R.P., Cantor A., et al. Genetic staging of unresectable or metastatic neuroblastoma in infants: A Pediatric Oncology Group study. J Natl Cancer Inst 89 (1997) 373-380
27. Haas-Kogan D.A., Swift P.S., Selch M., et al. Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study. Int J Radiat Oncol Biol Phys 56 (2003) 28-39
28. Kaufman B.H., Gunderson L.L., Evans R.G., et al. Intraoperative irradiation: A new technique in pediatric oncology. J Pediatr Surg 19 (1984) 861-862
29. Haase G.M., Meagher D.P., McNeely L.K., et al. Electron beam intraoperative radiation therapy for pediatric neoplasms. Cancer 74 (1994) 740-747
30. Zelefsky M.J., LaQuaglia M.P., Ghavimi F., et al. Preliminary results of phase I/II study of high-dose-rate intraoperative radiation therapy for pediatric tumors. J Surg Oncol 62 (1996) 267-272
31. Kuroda T., Saeki M., Honna T., et al. Clinical significance of intensive surgery with intraoperative radiation for advanced neuroblastoma: Does it really make sense?. J Pediatr Surg 38 (2003) 1735-1738
32. Oertel S., Niethammer A.G., Krempien R., et al. Combination of external-beam radiotherapy with intraoperative electron-beam therapy is effective in incompletely resected pediatric malignancies. Int J Radiat Oncol Biol Phys 64 (2006) 235-241
33. Kushner B.H., Wolden S., LaQuaglia M.P., et al. Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery. J Clin Oncol 19 (2001) 2821-2828
34. Zachariou Z., Sieverts H., Eble M.J., et al. IORT (intraoperative radiotherapy) in neuroblastoma: Experience and first results. Eur J Pediatr Surg 12 (2002) 251-254
35. Klaassen R.J., Trebo M.M., Koplewitz B.Z., et al. High risk neuroblastoma in Ontario: A report of experience from 1989 to 1995. J Pediatr Hematol Oncol 25 (2003) 8-13
36. Kaneko M., Tsuchida Y., Mugishima H., et al. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol 24 (2002) 613-621